What was NP explaining at the Shareholder meeting or a video before (can’t remember but I’ll see if I can find it when I get a little time) about needing a decision from FDA about 525 and 700 as something was different in the CMC portion.....I believe he said they could work that simultaneously with clinical portion if they knew?